.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Lobo is stocked at 51 licensed dispensaries across New York and New Jersey, 39 of them in New York, with the deepest coverage in New York, Queens, Brooklyn, Staten Island, and Ballston Spa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Lobo’s mix concentrated 51.6% in Flower and 33.9% in Pre-Roll, with a smaller 14.4% in Concentrates; YoY, Flower declined 41.9% while Pre-Roll fell 40.4%, and MoM, Flower slipped 3.2% as Pre-Roll rose 5.4%. Concentrates contracted 24.7% YoY and 26.0% MoM, coinciding with a 22.2% YoY average price drop at the brand level and an overall sales decline of 39.4% YoY, implying a demand shift toward lower-priced format mix where Pre-Roll gained share momentum at the expense of Concentrates. The pattern implies Lobo is leaning into volume-driven Pre-Rolls while Flower remains the anchor, but the double-digit MoM pullback in Concentrates signals a retreat from higher-complexity offerings that could narrow premium reach.
Positioning-wise, a 51.6% Flower weight paired with an 80th rank in Flower in New York and a 5.4% MoM lift in Pre-Roll suggest Lobo’s near-term defensibility comes from trading customers into accessible Pre-Rolls rather than recovering Flower velocity. With brand sales down 39.4% YoY and the category skew moving away from a 26.0% MoM-declining Concentrates slice, the brand is de-emphasizing higher-ticket formats as its average price fell 22.2% YoY, implying a value-tilted stance that prioritizes unit throughput over premium margin capture.
Competitive Landscape
Lobo sits at rank #80 in NY Flower in October 2026, down 32 positions year over year from #48, and it has slipped 5 places since July 2026 from #85 to #80 while never reclaiming its peak of #48 from November 2025; meanwhile, Leal improved from #2 to #1 with 31.5% YoY sales growth and Find. advanced from #5 to #2 with 36.2% YoY sales growth, indicating Lobo’s relative share is likely being redistributed upward as leaders consolidate positions, so the trajectory implies entrenchment in the lower tier unless a rank recovery strategy counters competitor gains.
Notable Products
Lobo leans on newly launched items in October 2026, with 12 products released in the last six months contributing 37.5% of brand sales and placing items like Blueberry Diesel Infused Flower (3.5g) and Permanent Marker Hash (1g) in the top tier. That level of turnover means a large share of sales comes from recent launches rather than long-running staples.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
